Abstract.-A new nondefective hybrid virus has been plaque-isolated from the Ad.2-SV40 hybrid population. This virus replicates efficiently with one-hit kinetics in both human embryonic kidney and African green monkey kidney cells, induces an SV40 specific antigen which is detectable by immunofluorescence and complement-fixation using sera from SV40 tumor-bearing hamsters, and produces SV40-specific RNA detectable by DNA-RNA hybridization. The SV40-specific antigen induced by this virus is heat-stable, sensitive to inhibitors of DNA synthesis, serologically different from SV40 T and viral antigens, and is an unrecognized SV40 antigen.
Since the initial reports describing the hybridization of human adenoviruses (Ad.) and SV40, two types of hybrid populations have been described: those free of detectable SV40 virions represented by the Ad.3 and Ad.7 populations; and those which release detectable SV40 virions represented by the Ad.1, 2, 4, 5, and 12 populations.'-3 Characterization of the infectivity and the SV40 T antigen-inducing capacity of the progeny of plaques isolated from human embryonic kidney (HEK) and African green monkey kidney (AGMK) cells have established that these hybrid populations consist of a mixture of nonhybrid Ad. virions and hybrid particles containing SV40 genome in Ad. capsids. [4] [5] [6] [7] Studies on adenovirus plaque formation by the two types of Ad.-SV40 hybrid populations have shown that the nonhybrid component induces adenovirus plaques by one-hit kinetics in human embryonic kidney cells, indicating that one virion initiates plaque formation. In green monkey kidney cells, however, the induction of adenovirus plaques by these populations proceeds by two-hit kinetics, indicating that both a nonhybrid adenovirion and a defective hybrid particle (i.e., a particle requiring nonhybrid adenovirus to replicate in either human embryonic or green monkey kidney cells) are required to initiate adenovirus plaque formation.2' [4] [5] [6] [7] Biological and biophysical studies on the Ad.7-SV40 hybrid population, E46 +, have shown that the adenovirus and SV40 DNA in these hybrid particles is covalently linked; thus, these particles are true molecular hybrids.8-'0 All efforts to obtain a pure clone of E46+ hybrid particles free of nonhybrid adenovirions have failed. 4 Biological studies on the Ad.2-SV40 (Ad.2++) t population have demonstrated that, in addition to nonhybrid Ad.2 virions, there are adenovirus encapsidated particles which are capable of producing SV40 plaques on AGMK monolayers by one-hit kinetics.2 These particles contain the infectious SV40 genome.
The purpose of this paper is to describe the isolation from the Ad.2++ popula-tion of a new type of Ad.-SV40 hybrid virus. Designated Ad.2+ND1, this virus is nondefective, produces SV4O-specific RNA, a previously unrecognized SV4O-specific antigen, and does not yield infectious SV40 virus.
Materials and Methods.-Virus: Pool 2 of the Ad.2++ population has been previously described.2 Pools B56 and B55, representing the progeny from plaques 1208 (described in detail elsewhere)" and 1562 (later designated the Ad.2+NDPl pool), constitute the third and fourth AGMK passages, respectively, of plaques that were isolated from two-hit titrations in AGMK cells of Ad.2++ pool 2. The infectivity characteristics of these pools are presented in Table 2 .
Ad.2 (strain Ad.6) and Ad.12 (Huie strain) were maintained by serial passage in either HEK or KB cells. The pools used for DNA extraction were purified by Dr. Paul Burnett of Eli Lilly Co., Indianapolis, Indiana."2 SV40 strain 777,11 maintained by serial passage in BSC-1 cells, was used for preparation of SV40 DNA. Prior to extraction of the viral DNA, the virus was purified by the method of Black et al. '4 Plaque assays: The techniques for HEK and AGMK plaque assays with and without adenovirus lawns, and the procedures used to isolate and pass plaque isolates, have been described in detail elsewhere.2 "
In order to disperse aggregates prior to plaque titrations, an aliquot of each virus pool was treated with 1% sodium deoxycholate and 0.1% trypsin for 30 min at 3700,14 extracted for 15 min at 4°C with an equal volume of cold chloroform, clarified at 1500 rpm X 10 min, diluted 1-10 in medium containing 10% fetal bovine serum, and stored until assayed at -70°C.
Antigen preparation: The techniques used for preparing coverslip antigens with and The techniques used to prepare the hyperimmune adenovirus rabbit antiserum (RAS) and SV40 RAS specific for SV40 viral (V) antigen have been described elsewhere."'"a The SV40 RAS used was from a single rabbit and had an FA titer of 1-160 anti-SV40 V antibody and no reaction by FA at 1-10 with SV40 T antigen.
The guinea pig serum specific for SV40 V antigen (obtained from Dr. Ml. D. Hoggan) failed to react by complement fixation (CF) at a 1/20 dilution with SV40 T antigen but had a titer of 1/2560 when tested against SV40 cell pack antigen.
The FA procedure used in these experiments was the method of Pope and Rowe for staining T antigen. '6 Nucleic acid extraction and RNA-DNA infection, cells were removed by scraping and pelleted at 1500 rpm X 10 min. The procedures for extraction of RNA from these cells, the technique of RNA-DNA hybridizatioli, and the method of elution and rehybridization have been )reviously described."8 KB and Vero cell DNA was extracted by the method of Martnur,'9 and DNA from purified virus was prepared by papain digestion followed by SDS-phenol extraction.20
Results.-Isolation of the Ad.2+ND, virionr in HEK: Ten selected adenovirus plaques were isolated from two-hit titrations in AGMK monolayers infected with the parent Ad.2++ pool 2. All ten pools prepared from the progeny of these plaques induced SV40 antigen detectable by immunofluorescence. Infectivity studies on one of these pools suggested the existence of nondefective virions. Pool B55, designated the Ad.2+NDPl pool, plaqued with nearly equal efficiency in both HEK and AGMK monolayers with dose-response curves following one-hit kinetics. This was in marked contrast to the pools prepared from the progeny of the other nine plaques; each formed adenovirus plaques at high dilutions by one-hit kinetics in HEK monolayers, while forming such plaques at lower dilutions, and by two-hit kinetics in AGMK monolayers. Moreover, five of five subplaques of Ad.2+NDPl isolated from the HEK monolayers induced SV40 antigens detectable by immunofluorescence in 2-70 per cent of the nuclei, whereas none of 28 HEK plaque progeny of the parent Ad.2++ pool 2 induced FA detectable SV40 antigen in HEK.
To determine whether the Ad.2+NDPl pool did contain Ad.2-SV40 hybrid particles capable of independent replication in both HEK and AGMK cells, a series of three plaque isolation procedures on HEK monolayers was performed. Before each subsequent plaque isolation step, the isolated plaques were passed in HEK cells and their progeny were tested by immunofluorescence for induction of SV40 antigens. By these procedures the plaque isolation series provided the conditions necessary for the simultaneous selection of nondefective hybrid virions and the detection of nonhybrid Ad.2 which may have been present in the Ad.2+-NDjP1 pool. A summary of these plaque isolation studies is presented in Table 2 and are compared with similar tities of SV40 virions. The induction of SV40 plaques by these pools followed onehit kinetics, and the formation of these SV40 plaques was neutralized by Ad.2 RAS. To demonstrate that pools of the Ad.2+ND, virus were free of SV40
virions, 50-ml aliquots of the Ad.2+ND1Pl and P9 pools were freed of Ad.2 encapsidated virions by heat inactivation and were passed in 32-oz bottle cultures of AGMK cells for 30 days with a subsequent blind passage in one experiment. No SV40 virions were detected in either of these pools. Thus, the Ad.2+ND1 virus is not defective in either human embryo or African green monkey kidney cells, replicating with one-hit efficiency in both cell types in the absence of nonhybrid Ad. virions. To prove that this virus was an Ad.-SV40 hybrid, it was necessary to show that it contained SV40 genome. This was done by demonstrating that it induced both SV40-specific antigen and SV40-specific RNA.
Production of SV40-specific antigen by the Ad.2+ND, virus: During the immunofluorescent evaluation of the progeny from plaque isolates from the Ad.2+ND1P3 pool, a dramatic difference was noted in the morphology of the immunofluorescent staining reaction detected with SV40 serum from tumorbearing hamsters (Table 1 ). The Ad.2+NDPl pool had induced an FUDRresistant, intranuclear antigen which was morphologically indistinguishable from that previously described for SV40 T antigen. The five subplaques from this pool induced a morphologically similar antigen. However, seven of ten subplaques from the progeny (the Ad.2+ND1P3 pool) of one of the Ad.2+ND1Pl plaques induced an antigen with an entirely different morphology when stained with the same pool of SV40 hamster serum. The immunofluorescent staining reaction of the antigen induced by these plaques was seen only at the nuclear membrane and perinuclear area of the cell. This unusual morphologic pattern was observed in immunofluorescent studies of all the subsequent subplaques from the Ad.2 +ND, population regardless of whether HEK, AGMK, or rat embryo cells were used to prepare the antigens. Cells infected with Ad.2+ND, virus failed to react with a variety of pooled and individual sera from hamsters bearing transplanted tumors induced by Ad.7, 12, 18, polyoma, and Rous sarcoma virus. Additional immunofluorescent studies demonstrated that this antigen reacted with a great majority of sera from SV40 tumor-bearing ham-sters. In contrast to SV40 T antigen, it was sensitive to inhibitors of viral DNA synthesis, FUDR, or cytosine arabinoside, and was not inactivated by heating coverslips to 560C for 30 minutes. In contrast to the SV40 V antigen, which is induced in AGMK cells by SV40 virus or in HEK cells by either Ad.2++ pools 2 or B56,2' 11, 13 the antigen induced by Ad. 2+ND1 virus did not react with SV40 hyperimmune rabbit or guinea pig sera specific for SV40 V antigen. The nuclear membrane staining was reduced 90-97% per cent by mixing the Ad.2+ND, virus with Ad.2 RAS, while no reduction in per cent staining was detected by mixing the inoculum with either a preimmune serum from the same rabbit, SV40 RAS, or a complement-fixation reactive pool of sera from SV40 tumorbearing hamsters. The SV40 specificity and the general properties of this antigen were confirmed by complement-fixation testing. Serologic reagents specific for other agents including adeno-associated viruses 1-4, SV5, and lymphocytic choriomeningitis failed to react with this antigen by either immunofluorescence or complement fixation. This SV40-specific antigen, which differs strikingly from both SV40 T and V antigen by immunofluorescence and complement fixation, is most likely a previously unrecognized SV40 antigen and has been designated the SV40 "U" antigen. A more detailed characterization of this antigen will be presented in a subsequent report. genomes. An alternative model is that the entire SV40 genome is included within each hybrid particle with different portions of the genome being expressed.
The finding that a non-T antigen-inducing Ad.-SV40 hybrid particle will replicate efficiently in AGMK cells also suggests that the portion of the SV40 genome responsible for enhancement of adenoviruses in AGMK cells is different from that which induces T antigen. It cannot be ruled out that the Ad.2+ND1 virus is a monkey cell-adapted Ad.2 mutant that contains a portion of the SV40 genome but lacks the segment responsible for enhancing the replication of human adenoviruses in monkey cells.
The Ad.2+ND, virus is a laboratory-created hybrid virion which is unique because of its nondefective nature; this virus should prove to be much more useful in studying the molecular interaction of the adenovirus and SV40 DNA's than the hybrid particles described heretofore. The pathogenicity of nondefective viruses which are hybrids between human pathogens and other viral agents such as SV40 must be considered. Such viruses could be maintained in human and subhuman populations and as pathogens would represent unknown hazards. Preliminary studies in hamsters have indi-cated that the Ad.2+ND, virus is not oncogenic since after 360 days it has produced no tumors in 28 hamsters inoculated as newborns with 107 pfu. Likewise, no evidence of transformation has been detected in hamster embryo cultures after 90 days.
